SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ISGTF or ISO Toronto shares traded 400,000 shares May 24 -- Ignore unavailable to you. Want to Upgrade?

To: Sultan who wrote (73)9/18/1998 8:47:00 AM
From: Link Lady  Read Replies (1) | Respond to of 112
 
"ISG today is a growth company with positive cash flow, mounting
revenues, no debt, $ 20 million in cash, a lengthening roster of
products and clients, and a $ 41 million order backlog, " says
Michael M. Greenberg, MD, Chairman and Chief Executive Officer of
ISG. "Although we are pleased with this progress, it is a stepping
stone from which ISG must now press on to accelerated earnings."
news.com



To: Sultan who wrote (73)10/3/1998 4:33:00 AM
From: Link Lady  Read Replies (2) | Respond to of 112
 
+Wendy Cusack (75 )
From: +joe kaminsky
Saturday, Oct 3 1998 1:30AM ET
Reply # of 76

IMO isgtf is a realistic takeover candidate. One possible acquirer is
analogic corp (alog). They are an OEM co. with strong products in the
medical imaging field. Possible price 6-7. What do you think?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News